These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 28236139)

  • 21. Update on Restless Legs Syndrome: from Mechanisms to Treatment.
    Gonzalez-Latapi P; Malkani R
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):54. PubMed ID: 31250128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron and restless legs syndrome: treatment, genetics and pathophysiology.
    Connor JR; Patton SM; Oexle K; Allen RP
    Sleep Med; 2017 Mar; 31():61-70. PubMed ID: 28057495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restless legs syndrome: a review of clinical and pathophysiologic features.
    Allen RP; Earley CJ
    J Clin Neurophysiol; 2001 Mar; 18(2):128-47. PubMed ID: 11435804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome.
    Walters AS; Li Y; Koo BB; Ondo WG; Weinstock LB; Champion D; Afrin LB; Karroum EG; Bagai K; Spruyt K
    Brain; 2024 Jan; 147(1):26-38. PubMed ID: 37633259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis.
    Pereira JC; Pradella-Hallinan M; Lins Pessoa Hd
    Clinics (Sao Paulo); 2010 May; 65(5):548-54. PubMed ID: 20535374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restless legs syndrome.
    Ekbom K; Ulfberg J
    J Intern Med; 2009 Nov; 266(5):419-31. PubMed ID: 19817966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathophysiology of restless legs syndrome].
    Monaca C
    Presse Med; 2010 May; 39(5):587-91. PubMed ID: 20346613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular basis of restless legs syndrome.
    Freeman AA; Rye DB
    Curr Opin Neurobiol; 2013 Oct; 23(5):895-900. PubMed ID: 23896312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain, opioids, and sleep: implications for restless legs syndrome treatment.
    Trenkwalder C; Zieglgänsberger W; Ahmedzai SH; Högl B
    Sleep Med; 2017 Mar; 31():78-85. PubMed ID: 27964861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restless legs syndrome: pathophysiology, clinical presentation and management.
    Trenkwalder C; Paulus W
    Nat Rev Neurol; 2010 Jun; 6(6):337-46. PubMed ID: 20531433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New paradigms in the treatment of restless legs syndrome.
    Thorpy MJ
    Neurology; 2005 Jun; 64(12 Suppl 3):S28-33. PubMed ID: 15994221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic Treatment of Restless Legs Syndrome.
    Lv Q; Wang X; Asakawa T; Wang XP
    Curr Neuropharmacol; 2021; 19(3):372-382. PubMed ID: 33380302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA.
    Lanza G; Ferri R
    Adv Pharmacol; 2019; 84():101-119. PubMed ID: 31229167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurobiology and treatment of restless legs syndrome.
    Jones R; Cavanna AE
    Behav Neurol; 2013; 26(4):283-92. PubMed ID: 22713426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice.
    Salminen AV; Lam DD; Winkelmann J
    Adv Pharmacol; 2019; 84():175-184. PubMed ID: 31229170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological disorders: towards a mechanistic understanding of restless legs syndrome.
    Shaw PJ; Duntley SP
    Curr Biol; 2012 Jun; 22(12):R485-6. PubMed ID: 22720681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restless legs syndrome: a review.
    Chahine LM; Chemali ZN
    CNS Spectr; 2006 Jul; 11(7):511-20. PubMed ID: 16816791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.